| NCT ID | NCT07295197 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Bologna |
| Condition | Eating Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 461 participants |
| Start Date | 2025-11-14 |
| Primary Completion | 2026-04-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 461 participants in total. It began in 2025-11-14 with a primary completion date of 2026-04-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective of this research project is to explore the capability of a standardized, evidence-based study tool (the OHEDs Checklist) in the early identification of oro-dental manifestations potentially indicative of an eating disorder. The secondary objective is to evaluate the sensitivity and specificity of the OHEDs Checklist in comparison with validated screening instruments for eating disorders, namely the ESP, SCOFF and DEQ questionnaires.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 40 years * Presence of at least 20 permanent teeth (third molars excluded) * Both males and females are eligible * Ability to provide written informed consent Exclusion Criteria: * Pregnancy or breastfeeding * Use of systemic antibiotics within the previous month * Active orthodontic treatment * Presence of systemic diseases that may affect oral conditions, including: diabetes, ulcerative colitis, Crohn's disease, Sjögren's syndrome, HIV infection, hematologic diseases, neoplasms * Mental disorders or neuromotor deficits that may interfere with the oro-dental clinical signs evaluated by the OHEDs Checklist * Use of xerogenic medications or drugs that may alter salivary flow or oral/perioral mucosal conditions, including: antihypertensives, beta-blockers, non-steroidal anti-inflammatory drugs (NSAIDs), antiparkinson medications, anxiolytics, antidepressants, neuroleptics
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07295197 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07295197 currently recruiting?
Yes, NCT07295197 is actively recruiting participants. Contact the research team at m.montevecchi@unibo.it for enrollment information.
Where is the NCT07295197 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT07295197 clinical trial?
NCT07295197 is sponsored by University of Bologna. The trial plans to enroll 461 participants.